S'abonner

Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency - 09/01/21

Doi : 10.1016/j.jaci.2020.04.033 
Maria Carmina Castiello, PhD a, b, , Marita Bosticardo, PhD c, , Nicolò Sacchetti, PhD a, Enrica Calzoni, MD a, c, Elena Fontana, PhD b, d, Yasuhiro Yamazaki, MD, PhD c, Elena Draghici, BS a, Cristina Corsino c, Ileana Bortolomai, PhD a, Lucia Sereni, PhD a, Hsin-Hui Yu, MD, PhD c, Paolo Uva, PhD e, Rahul Palchaudhuri, PhD f, g, h, David T. Scadden, MD f, g, Anna Villa, MD a, b, , Luigi D. Notarangelo, MD c,
a San Raffaele Telethon Institute for Gene Therapy SR-Tiget, IRCCS San Raffaele Scientific Institute, Milan, Cagliari, Italy 
b Institute of Genetic and Biomedical Research Milan Unit, National Research Council, Milan, Cagliari, Italy 
c Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md 
d Human Genome Lab, Humanitas Clinical and Research Center, Milan, Cagliari, Italy 
e CRS4, Science and Technology Park Polaris, Pula, Cagliari, Italy 
f Department of Stem Cell and Regenerative Biology, Harvard University, Harvard Stem Cell Institute, Cambridge, Mass 
g Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Mass 
h Magenta Therapeutics, Cambridge, Mass 

Corresponding author: Anna Villa, MD, SR-Tiget, Via Olgettina 58, Milan, 20127, Italy.SR-TigetVia Olgettina 58Milan20127Italy∗∗Luigi D. Notarangelo, MD, Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 5-3950, 10 Center Drive, Bethesda, MD 20892.Immune Deficiency Genetics SectionLaboratory of Clinical Immunology and MicrobiologyNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBuilding 10Room 5-395010 Center DriveBethesdaMD20892

Abstract

Background

Mutations in the recombinase-activating genes cause severe immunodeficiency, with a spectrum of phenotypes ranging from severe combined immunodeficiency to immune dysregulation. Hematopoietic stem cell transplantation is the only curative option, but a high risk of graft failure and poor immune reconstitution have been observed in the absence of myeloablation.

Objectives

Our aim was to improve multilineage engraftment; we tested nongenotoxic conditioning with anti-CD45 mAbs conjugated with saporin CD45 (CD45-SAP).

Methods

Rag1-KO and Rag1-F971L mice, which represent models of severe combined immune deficiency and combined immune deficiency with immune dysregulation, respectively, were conditioned with CD45-SAP, CD45-SAP plus 2 Gy of total body irradiation (TBI), 2 Gy of TBI, 8 Gy of TBI, or no conditioning and treated by using transplantation with lineage-negative bone marrow cells from wild-type mice. Flow cytometry and immunohistochemistry were used to assess engraftment and immune reconstitution. Antibody responses to 2,4,6-trinitrophenyl–conjugated keyhole limpet hemocyanin were measured by ELISA, and presence of autoantibody was detected by microarray.

Results

Conditioning with CD45-SAP enabled high levels of multilineage engraftment in both Rag1 mutant models, allowed overcoming of B- and T-cell differentiation blocks and thymic epithelial cell defects, and induced robust cellular and humoral immunity in the periphery.

Conclusions

Conditioning with CD45-SAP allows multilineage engraftment and robust immune reconstitution in mice with either null or hypomorphic Rag mutations while preserving thymic epithelial cell homeostasis.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : RAG deficiency, conditioning, anti-CD45–saporin, immunotoxin, engraftment, immune reconstitution, hematopoietic stem cell transplantation, thymic epithelial cells

Abbreviations used : ADC, BM, CD45-SAP, CID-ID, DN, HSC, HSCT, HSPC, Lin, LSK, mTEC, MZ, PB, RAG, SCID, TBI, TEC, TNP, WBC, WT


Plan


 Supported by a grant from the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (to L.D.N.); the National Institutes of Health Bench to Bedside grant RAG Deficiency: From Pathophysiology to Precise Gene Editing (to L.D.N. and A.V.); and grants Tiget E2 (to A.V.), Italian Ministry of Health PE-2016-02363691 (to E.F. and L.D.N.), EU2020 (SCIDNET) No. 666908 (to A.V.), and MIUR 2017-5XHBPN (to A.V.).
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2020  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 147 - N° 1

P. 309 - janvier 2021 Retour au numéro
Article précédent Article précédent
  • Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis
  • Bernardo Sousa-Pinto, Isabel Tarrio, Kimberly G. Blumenthal, Luís Araújo, Luís Filipe Azevedo, Luís Delgado, João Almeida Fonseca
| Article suivant Article suivant
  • Cow’s milk protein ?-lactoglobulin confers resilience against allergy by targeting complexed iron into immune cells
  • Franziska Roth-Walter, Sheriene Moussa Afify, Luis F. Pacios, Bart R. Blokhuis, Frank Redegeld, Andreas Regner, Lisa-Marie Petje, Alessandro Fiocchi, Eva Untersmayr, Zdenek Dvorak, Karin Hufnagl, Isabella Pali-Schöll, Erika Jensen-Jarolim

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.